Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2022

Feb 24, 2022

32044_dirs_2022-02-24_ea3d7cb9-316a-44a0-887e-1f430c20518f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-02-22

Reporting Person: SHAPIRO ROBERT B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-22 Common Stock A 31034 $2.03 Acquired 224945 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-22 Restricted Stock Units $ A 61576 Acquired Common Stock (61576) Direct
2022-02-22 Option to Purchase Common Stock (Right to Buy) $2.03 A 83189 Acquired 2032-02-22 Common Stock (83189) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 82966 Indirect

Footnotes

F1: The shares were issued to the reporting person in lieu of an annual retainer of $63,000.

F2: Shares held in the Robert B. Shapiro Revocable Trust

F3: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.

F4: The RSUs vest in full on February 22, 2023.